Ev
Non vérifié

Evaxion

Ce que nous écrivons

Annonces ÉconomiquesBiotechnologieFinancePublicité/Marketing/Médias/Communication
20/11/2025
Biotechnologie
Annonces Économiques
Evaxion announces positive data for lead antigens in cytomegalovirus (CMV) vaccine program EVX-V1
Source
1.00
12/11/2025
Biotechnologie
Annonces Économiques
Evaxion announce 2026 financial calendar
Source
1.00
06/11/2025
Biotechnologie
Annonces Économiques
Evaxion announces business update and third quarter 2025 financial results
Source
1.00
03/11/2025
Biotechnologie
Annonces Économiques
Evaxion expands R&D pipeline with new AI-designed precision cancer vaccine candidate
Source
1.00
31/10/2025
Biotechnologie
Annonces Économiques
Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025
Source
1.00
30/10/2025
Biotechnologie
Annonces Économiques
Evaxion raises $7.2 million, extending cash runway to second half of 2027
Source
1.00
27/10/2025
Biotechnologie
Annonces Économiques
Evaxion appoints Dr Helen Tayton-Martin as new Chief Executive Officer
Source
1.00

Détails du contact

Réseaux sociaux

Followers
0
Compatibilité
0